Profile | GDS2987 / GI_7656966-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 3.5 | 13 |
GSM215244 | HMVEC_vehicle_rep2 | 18.8 | 43 |
GSM215253 | HMVEC_vehicle_rep3 | 34.8 | 66 |
GSM215254 | HMVEC_atorvastatin_rep1 | 13.9 | 35 |
GSM215282 | HMVEC_atorvastatin_rep3 | 28.5 | 54 |
GSM215344 | HMVEC_atorvastatin_rep2 | 27.3 | 54 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 34.7 | 55 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 25.3 | 45 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | 15.5 | 48 |
GSM215295 | HMVEC_SLx2119_rep2 | 11.7 | 24 |
GSM215296 | HMVEC_SLx2119_rep3 | 21.5 | 35 |
GSM215297 | PASMC_vehicle_rep1 | 10.8 | 17 |
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | 41.6 | 55 |
GSM215311 | PASMC_atorvastatin_rep1 | 6.5 | 12 |
GSM215312 | PASMC_atorvastatin_rep2 | 16.6 | 26 |
GSM215313 | PASMC_atorvastatin_rep3 | 32.5 | 44 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 0.4 | 1 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | 22.2 | 37 |
GSM215328 | PASMC_SLx2119_rep2 | 2.5 | 5 |
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 19.2 | 41 |
GSM215331 | Fibroblasts_vehicle_rep2 | 5 | 15 |
GSM215332 | Fibroblasts_vehicle_rep3 | 13.2 | 40 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 18.9 | 45 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 20.2 | 48 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 34.5 | 60 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 1.8 | 6 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 6.2 | 20 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 29.6 | 60 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 12.7 | 36 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 16.2 | 42 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 26.9 | 54 |